Sunshine Biopharma Inc Warrant
SBFMW
3 hedge funds and large institutions have $13.3K invested in Sunshine Biopharma Inc Warrant in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
8% more capital invested
Capital invested by funds: $12.3K → $13.3K (+$942)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.07% less ownership
Funds ownership: 0.21% → 0.14% (-0.07%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$1.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$7.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$132 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $12.2K | -$7.7K | -14,753 | -38% |
|
|
CS
2
Clear Street
New York
| $988 | +$1.03K | +1,976 | New |
|
3
Bank of America
Charlotte,
North Carolina
| $50 | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$132 | -400 | Closed |
|
SBFMW Hedge Fund Activity: Q1 2023 in Review
3 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q1 2023, worth a combined $13.3K — up 7.6% from $12.3K a quarter earlier.
Fund positioning in SBFMW was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Clear Street, opening a new position worth an estimated $1.03K. The largest seller was Susquehanna International Group, cutting an estimated $7.7K.
- 3 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $13.3K of Sunshine Biopharma Inc Warrant stock for Q1 2023, up 7.6% quarter-over-quarter.
- 1 fund opened new Sunshine Biopharma Inc Warrant positions in Q1 2023 and 1 closed out, a net change of 0 holders.
- The largest Sunshine Biopharma Inc Warrant buyer in Q1 2023 was Clear Street, an estimated $1.03K added.
- The largest Sunshine Biopharma Inc Warrant seller in Q1 2023 was Susquehanna International Group, an estimated $7.7K sold.
Based on aggregated 13F filings for Q1 2023.